Two health facilities of The United Methodist Church in Liberia have confirmed that most of the Ebola survivors seeking care have complaints about
Headlines for Ebola
Powered By Bing News
So, adding to the list of annoying celebrities who don’t understand how Ebola is transmitted, our girl Ariana Grande dipped out on a charity event
MONROVIA, Montserrado – The Ebola Survivor Network of Liberia will hold a fundraising rally for Ebola orphans and child survivors today at noon at
In 2014, the world was left shaken by the most serious outbreak of Ebola ever seen.
Via DallasNews.com: Ebola nurse Nina Pham close to settlement with Texas Health Resources.
Ottawa (AFP) - An Ebola vaccine developed by Canadian researchers and considered by the WHO to be the first effective treatment against the virus w
Rubins, 38, has a Ph.D. in cancer biology.
The Canadian Ebola vaccine will soon enter new trial phase, meaning it’s one step closer to being used.
(Dallas, TX) -- Texas Health Resources may be close to settling a lawsuit filed by a nurse who caught the Ebola virus while caring for the first pe
Monrovia — The Partnership for Research on Ebola Virus in Liberia (PREVAIL) on Wednesday held a daylong community engagement and awareness forum wi
HAZEL — Roger and Melanie Reiners and Dr. Lowell Gess will discuss their work in Africa at a 9 a.m. Oct.
Two years after the Ebola crisis hit Dallas, one of the nurses infected is still pursuing a lawsuit against Texas Health Presbyterian Hospital, whe
Future infectious disease epidemics are likely to disproportionately affect countries with weak health systems, exacerbating global vulnerability.
Filoviruses are capable of causing deadly hemorrhagic fevers.
Therefore, the message is baseless and not truthful.
Attorneys for Ebola nurse Nina Pham and Texas Health Resources told a judge today that they are close to reaching a settlement, according to a sour
Xinhua News: Ebola deaths preventable with more emergency health facilities: Aussie researchers “Australian researchers in an international-led stu
DALLAS (CBSDFW.COM) – One of the two Presybterian Hospital Dallas nurses who contracted Ebola two years ago may have settled part of her lawsuit.
A clinical trial to evaluate the experimental Ebola treatment ZMapp found it to be safe and well-tolerated; however, because of the waning Ebola ep
Abdullah Kiatamba, the Executive Director of African Immigrant Services, located in Brooklyn Park, is working with other organizations to allow peo
Emergency health facilities could be the key to survival for Ebola patients, an international study involving University of Queensland researchers
[ANTWERP, BELGIUM] The next Ebola outbreak could have a prime-boost vaccine available, particularly for health workers and vulnerable communities o
Nurse Nina Pham, one of the Texas Health Presbyterian Hospital Dallas nurses who contracted Ebola in 2014, has settled at least part of her lawsuit
SYDNEY, Oct.
CBS DFW reports that one of the two Presybterian Hospital Dallas nurses who contracted Ebola two years ago may have settled part of her lawsuit.
Some were even criticized for delays in responding to the exceedingly urgent Ebola crisis.
Liberia was one of three West African countries to participate at the 2016 Nanjing International Youth Sports and Cultural Week, having been invite
GOA (Sputnik) – Russian President Vladimir Putin suggested Sunday that the BRICS states should foster cooperative efforts in fighting dangerous dis
the spread of Ebola in West Africa and the Ebola patient in Dallas).
Ebola no longer dominates the headlines but for an estimated 17,000 survivors of the largest Ebola outbreak in history, the struggle is not over.
More than two years after the world's worst Ebola outbreak began in West Africa, health facilities in Liberia are struggling to operate due to
The Deputy Executive Director of the local NGO Children Education and Empowerment Initiative (CEEI) in Bomi County wants priority given to the educ
A study to find the cure to Ebola, the fatal illness which had its outbreak in 2014 in West Africa, has ended having inconclusive results.
When the deadliest Ebola outbreak in history tore through parts of West Africa in 2014, an experimental serum ZMapp was used in the lifesaving trea
More than 11,000 people died when Ebola swept through Guinea, Sierra Leone, and Liberia over a two-year period beginning in December 2013.
If you're unfortunate enough to wind up in hospital with a dangerous infectious disease like Ebola, then keep an eye on what your doctors are
This article was contributed by Jo Coone on behalf of Street Child.
In the midst of the 2014 Ebola outbreak, a drug called ZMapp was one of the most promising treatments for the disease.
Normal life has proved elusive for Ebola survivors who struggle with health complications and face discrimination from people who still fear the de
ZMapp was perhaps the most sought-after drug at the height of the Ebola crisis, but a clinical trial has failed to prove that patients who got the
ZMapp was perhaps the most sought-after drug at the height of the Ebola crisis, but a clinical trial has failed to prove that patients who got the
ZMapp was perhaps the most sought-after drug at the height of the Ebola crisis, but a clinical trial has failed to prove that patients who got the
Experimental Ebola drug ZMapp might not be as efficient in saving lives of Ebol patients as many believe, a new study cautioned.
MIAMI: ZMapp, once touted as a miraculous "secret serum" against the deadly Ebola virus, has shown some success but fell short of the bar
Miami (AFP) - ZMapp, once touted as a miraculous "secret serum" against the deadly Ebola virus, has shown some success but fell short of
ZMapp, an experimental drug that doctors thought may have helped save lives in recent high-profile Ebola cases, may not have been the key factor in
Nigeria has been Ebola-free since it narrowly avoided being sucked into the escalation of the highly contagious haemorrhagic fever outbreak which d
Data from studies in nonhuman primates suggest that the triple monoclonal antibody cocktail ZMapp is a promising immune-based treatment for Ebola v